Source: PaxForex Premium Analytics Portal, Technical Insight Gold fell in price on Tuesday, moving away from its all-time high as the dollar recovered, while silver fell by more than 9% in the trading, and investors switched their attention to the Fed meeting. GOLD/USD, 30 min Pivot: 1952.00 Analysis: Provided that the price is above 1945.00, please follow these recommendations: Time frame: 30 min Recommendation: long position Entry point: 1952.00 Take Profit 1: 1966.00 Take Profit 2: 1981.00 Alternative scenario:...
Source: PaxForex Premium Analytics Portal, Technical Insight Swiss pharmaceutical giant Roche has agreed to supply the EU with medicines for experimental treatment of coronavirus. The company, headquartered in Basel, has already signed a corresponding agreement with the European Commission. USD/CHF, 30 min Pivot: 0.9175 Analysis: Provided that the currency pair is traded below 0.9190, follow the recommendations below: Time frame: 30 min Recommendation: short position Entry point: 0.9175 Take Profit 1: 0.9160 Take...
Source: PaxForex Premium Analytics Portal, Technical Insight Intel's delayed chip shipments demonstrate why Apple decided to switch to manufacturing its own processors for the Mac. This decision was announced at Apple's developer conference last month. After switching to manufacturing its own processors, which Apple claims will take about two years, the company will have to rely more on Intel's production cycle. Apple's general manager Tim Cook said the first Macs running on their own chips will appear later this...
Source: PaxForex Premium Analytics Portal, Technical Insight The dollar continued its decline in European trading on Monday under the influence of doubts about the strength of the U.S. economic recovery and in anticipation of the Federal Reserve meeting on July 28-29 EUR/USD, 30 min Pivot: 1.1733 Analysis: Provided that the currency pair is traded below 1.1780, follow the recommendations below: Time frame: 30 min Recommendation: short position Entry point: 1.1733 Take Profit 1: 1.1705 Take Profit 2: 1.1680...
Source: PaxForex Premium Analytics Portal, Technical Insight Pfizer reported early positive results for a potential coronavirus vaccine that it is studying in partnership with BioNTech in a Phase 1/2 trial in Germany. Pfizer is working with BioNTech on four potential vaccines through a program called BNT162, which includes one of the most advanced candidates, BNT162b1. Pfizer, H4 Pivot: 37.25 Analysis: Provided that the asset is traded above 36.95, follow the recommendations below: Time frame: H4 Recommendation: long...
